A simple drug-delivery microneedling technique modality successfully improves linear atrophic scars

Area of Science:

• Dermatology
• Regenerative Medicine
• Aesthetic Medicine

Background:

• Atrophic scars result from collagen destruction and epidermal cell decrease, posing treatment challenges.
• Current treatments for atrophic scars are often limited, necessitating novel therapeutic approaches.
• Microneedling stimulates skin repair processes like angiogenesis and neocolagenesis.

Purpose of the Study:

• To evaluate a novel microneedling technique combined with 5-fluorouracil (5-FU) drug delivery for atrophic scar treatment.
• To assess the efficacy and patient/physician satisfaction with this combined therapeutic approach.
• To explore the potential of this minimally invasive procedure for improving scar appearance.

Main Methods:

• Eight patients with linear atrophic scars received two sessions of microneedling using a tattoo machine.
• 5-FU was administered via drug delivery concurrently with microneedling.
• Scar improvement was assessed by patients and physicians over a 6-month period.

Main Results:

• Significant improvements in scar pigmentation and texture were observed by both patients and physicians.
• High correlation was found between patient and physician assessment scores, indicating consistent evaluation.
• The cause of the original injury influenced treatment outcomes, suggesting personalized approaches may be beneficial.

Conclusions:

• The combination of microneedling and 5-FU drug delivery presents an inexpensive, promising in-office treatment for atrophic scars.
• This technique demonstrates potential as a first-line therapy for atrophic scar management.
• Larger, multicenter studies are required to validate these findings and establish the technique's role in clinical practice.